ImmunoGen hires legal chief

Nov 29, 2022
Daniel Char was previously general counsel at Evelo Biosciences

Nasdaq-listed ImmunoGen has hired Daniel Char as senior vice president and chief legal officer.

Char previously worked at Evelo Biosciences as general counsel and corporate secretary, providing counsel and operational support on business and legal issues such as business development, commercialization, healthcare fraud and intellectual property.

Before joining Evelo, he was associate general counsel and assistant secretary at Smith+Nephew, having previously been general counsel and secretary at Targanta Therapeutics, senior associate general counsel at Idenix Pharmaceuticals and associate general counsel at Biogen.

Daniel Char

Char succeeds Joseph Kenny, who has been acting general counsel and vice president since March 2020 and who will remain with the company as associate general counsel.

ImmunoGen operates in the field of antibody-drug conjugates for the treatment of cancer.

Mark Enyedy, the company’s president and CEO, says in a statement: ‘We are pleased to welcome Daniel to ImmunoGen to lead our legal team and join [our] executive committee. With his deep expertise advising on commercial, regulatory, compliance and corporate governance matters, Daniel will play an important role as we increase the scale and complexity of the business.’

Sign up to get stories direct to your inbox
Stay informed on the latest trends and developments in the fast-moving world of corporate governance by signing up for our popular newsletters. Our weekly and monthly updates will provide you with expert analysis, timely updates and comprehensive coverage of regulatory updates, governance trends and best practices, careers and much more.
Cs logo Cs logo